Our Pricing

The Science Behind How To Get The 5th Dose Out Of Mounjaro Pen

Published on: June 03, 2026

Many UK patients ask about how to get the 5th dose out of Mounjaro pen after completing their prescribed four injections. While pharmaceutical manufacturers include a small overfill in pre-filled injection pens to ensure accurate dosing, attempting to extract this residual medication raises important safety and efficacy concerns that every patient should understand before considering this practice.

Why Mounjaro Pens Contain Overfill: The Manufacturing Reality

Mounjaro KwikPens are manufactured with a deliberate overfill—typically 5-10% beyond the labelled four doses—to compensate for medication that remains in the needle hub, injection mechanism, and delivery pathway after each use [1]. This engineering design ensures that each of your four prescribed doses delivers the exact amount of tirzepatide specified on the pen label, whether that's 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg.

The overfill exists purely as a quality control measure, not as an additional therapeutic dose. Regulatory bodies including the MHRA require manufacturers to demonstrate consistent dose delivery across the pen's labelled lifespan, and overfill is the industry-standard solution to account for mechanical losses during injection [2].

When you complete your fourth injection, the residual medication visible in the pen cartridge represents this manufacturing buffer. The pen's dose selector will not advance to a fifth position because the device is calibrated to deliver only the four doses that have undergone clinical testing and regulatory approval.

The Clinical Risks of Extracting a 5th Dose from Your Mounjaro Pen

Attempting to extract residual medication from a Mounjaro pen after four doses introduces several significant clinical risks that can compromise both safety and treatment efficacy. First, the remaining volume is unpredictable—it may range from 0.3ml to 0.8ml depending on your injection technique across the previous four doses—making accurate dosing impossible without laboratory equipment [3].

Second, the pen mechanism is not designed for manual extraction. Patients attempting this procedure often resort to removing the cartridge, using insulin syringes to draw medication, or manipulating the dose selector beyond its calibrated range. Each method bypasses the sterile, single-use design that prevents bacterial contamination and ensures medication stability.

Third, tirzepatide's efficacy in the SURPASS trials was established using precise, consistent weekly dosing [1]. An unpredictable 'fifth dose' that may deliver anywhere from 1mg to 4mg of tirzepatide disrupts your treatment schedule and may trigger increased gastrointestinal side effects—nausea, vomiting, and diarrhoea—which are dose-dependent with GLP-1 receptor agonists.

What UK Prescribers Recommend Instead

Our UK clinical team at Cured Pharmacy consistently advises patients to use Mounjaro pens exactly as prescribed: four doses per pen, administered once weekly on the same day each week. If cost is a concern, discuss dose optimisation with your prescriber during your next consultation rather than attempting to extract residual medication. Some patients achieve their weight loss goals on lower maintenance doses after initial titration, which can reduce monthly costs while maintaining clinical benefit.

How Mounjaro Dosing Works: The SURPASS Trial Evidence

Mounjaro's dosing schedule is based on extensive clinical research, particularly the SURPASS programme involving over 10,000 participants [1]. The standard UK titration protocol begins at 2.5mg weekly for four weeks, then increases to 5mg weekly. Further increases to 7.5mg, 10mg, 12.5mg, or 15mg occur at four-week intervals based on individual response and tolerability.

In SURPASS-3, participants following this precise escalation achieved an average body weight reduction of 22.5% at the 15mg maintenance dose over 72 weeks [1]. This outcome was directly linked to consistent weekly dosing—not variable or improvised dose schedules. The trial protocol specifically required participants to inject the same dose at the same time each week to maintain stable tirzepatide plasma concentrations.

When you alter this schedule by attempting to extract a fifth dose, you introduce dosing variability that was never tested in clinical trials. Your prescriber calculates your treatment plan based on the assumption that each pen delivers exactly four consistent doses, and deviating from this framework may reduce the treatment's effectiveness.

Comparing Mounjaro Pen Design to Other Weight Loss Injections

Understanding how Mounjaro's pen mechanism differs from other GLP-1 treatments helps explain why extracting extra doses is particularly problematic. Wegovy pens, which contain semaglutide, are single-dose devices—each pen delivers one weekly injection with minimal residual medication [4]. Saxenda pens deliver daily 3mg doses with a multi-dose dial mechanism, but they're designed for 30 doses over 30 days with corresponding overfill calculations.

Mounjaro's KwikPen is engineered as a four-dose device with a fixed-increment dose selector. Unlike Saxenda's adjustable dial, you cannot manually select arbitrary doses. The pen clicks into position at your prescribed dose (2.5mg, 5mg, 7.5mg, etc.) and will not advance beyond the fourth injection. This design prevents accidental overdosing but also makes improvised dose extraction both difficult and unsafe.

The dual GIP/GLP-1 mechanism that makes Mounjaro uniquely effective—targeting both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors—also means that dose precision matters more than with single-pathway treatments [1]. Variable dosing may disproportionately activate one receptor pathway over another, potentially altering the treatment's metabolic effects.

What This Means for Your Treatment Plan

If you're considering extracting a fifth dose to extend your prescription, this typically signals that treatment costs are a concern. At Cured Pharmacy, Mounjaro is available from £124.99 with transparent upfront pricing before your consultation. Our UK prescribers can discuss alternative dosing strategies, such as remaining on a lower maintenance dose if you've achieved significant weight loss, which may reduce your monthly expenditure while preserving clinical outcomes.

The Safety Case Against Using Mounjaro Pen Overfill

From a pharmaceutical safety perspective, the residual medication in your Mounjaro pen after four doses has not been tested for sterility beyond the pen's labelled use period. Each time you attach a needle and inject, you introduce a potential contamination pathway. The pen's rubber seal and internal mechanism are designed for four punctures—not five or more [2].

Additionally, tirzepatide's stability in the pen cartridge is validated for 21 days after first use when stored correctly at 2-8°C, or up to 21 days at room temperature below 30°C [3]. If you've been using your pen over the standard four-week period (one injection weekly), any residual medication is approaching or exceeding its validated stability window, potentially degrading into less effective or chemically altered compounds.

UK regulatory guidance from the MHRA emphasises that patients should never modify or manipulate pre-filled injection devices beyond their intended use. This includes attempting to extract residual medication, refilling cartridges, or using the device past its labelled dose count. Such practices void the manufacturer's safety guarantees and may result in adverse events that are not covered by standard pharmacovigilance monitoring.

Cost-Effective Mounjaro Access Without Compromising Safety

Rather than attempting to extract a fifth dose from your Mounjaro pen, consider these evidence-based strategies to optimise treatment value. First, discuss dose maintenance with your UK prescriber—many patients who reach their target weight loss on 10mg or 12.5mg weekly can maintain results on a lower dose, reducing monthly costs without regaining weight.

Second, ensure you're using your pen correctly to minimise medication waste during each injection. Prime the pen before each dose as instructed, inject slowly over 5-10 seconds, and keep the needle under your skin for an additional 10 seconds after the injection to ensure full dose delivery. Proper technique ensures you receive the complete prescribed dose from each pen without leaving excess medication in the needle hub.

Third, compare pharmacy pricing transparently. At Cured Pharmacy, Mounjaro starts from £124.99 with no hidden consultation fees—the price you see includes your UK prescriber assessment, dispensing, and discreet home delivery. This transparent pricing model helps you budget accurately without resorting to unsafe dose-stretching practices.

When to Contact Your Prescriber About Dosing Concerns

If you're considering extracting extra doses due to cost concerns, difficulty accessing repeat prescriptions, or confusion about your dosing schedule, contact your prescriber before attempting any pen modifications. Our UK clinical team at Cured Pharmacy is available to review your treatment plan, discuss dose adjustments, or address supply concerns through your patient account. Transparent communication about treatment barriers leads to safer, more effective solutions than improvised dosing strategies.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. European Medicines Agency. (2022). Guideline on the pharmaceutical quality of inhalation and nasal products. EMA/CHMP/QWP/49313/2013. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-quality-inhalation-nasal-products_en.pdf [accessed 13 August 2026]
3. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Never modify or attempt to extract additional doses from pre-filled injection pens beyond their labelled use.